NCT06732401 2026-03-18
Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Suspended
Clinical Trials
4 trialsNCT06159790 2026-03-04
A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
Sandoz
Phase 3 Suspended
NCT00540280 2011-03-08
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer
King Faisal Specialist Hospital & Research Center
Phase 3 Suspended
NCT00211952 2005-09-21
Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients
Medical University of Gdansk
Phase 3 Suspended